Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-04

Clinical Trial Update: Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating VCELL 1, an umbilical cord-derived mesenchymal stem cell product, for male sexual dysfunction; the study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VCELL 1 (Umbilical cord-derived mesenchymal stem cell)

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Sexual Dysfunction Male | Phase 1, Phase 2 | Status: RECRUITING